UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study

Journal of the American Academy of Dermatology, 2020-01, Vol.82 (1), p.139-148

2020

Volltextzugriff (PDF)

Functional and Clinical Relevance of Chondroitin Sulfate Proteoglycan 4

Advances in Cancer Research, 2010, Vol.109, p.73-121

2010

Volltextzugriff (PDF)

HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition

Seminars in immunopathology, 2011-07, Vol.33 (4), p.321-334

2011

Volltextzugriff (PDF)

Immunotherapy of Malignant Disease with Tumor Antigen–Specific Monoclonal Antibodies

Clinical cancer research, 2010-01, Vol.16 (1), p.11-20

2010

Volltextzugriff (PDF)

A prospective evaluation of the clinical, histologic, and therapeutic variables associated with incidental perineural invasion in cutaneous squamous cell carcinoma

Journal of the American Academy of Dermatology, 2014-04, Vol.70 (4), p.630-636

2014

Volltextzugriff (PDF)

Human Leukocyte Antigen and Antigen Processing Machinery Component Defects in Astrocytic Tumors

Clinical cancer research, 2005-12, Vol.11 (23), p.8304-8311

2005

Volltextzugriff (PDF)

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

Oncogene, 2008-10, Vol.27 (45), p.5869-5885

2008

Volltextzugriff (PDF)

Immune Selection of Hot-Spot β2 -Microglobulin Gene Mutations, HLA-A2 Allospecificity Loss, and Antigen-Processing Machinery Component Down-Regulation in Melanoma Cells Derived from Recurrent Metastases following Immunotherapy

The Journal of immunology (1950), 2005-02, Vol.174 (3), p.1462-1471

2005

Volltextzugriff (PDF)

Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance

Critical reviews in immunology, 2004, Vol.24 (4), p.267-296

2004

Volltextzugriff (PDF)

Classical and Nonclassical HLA Class I Antigen and NK Cell–Activating Ligand Changes in Malignant Cells: Current Challenges and Future Directions

Advances in Cancer Research, 2005, Vol.93, p.189-234

2005

Volltextzugriff (PDF)

HLA antigen expression in melanocytic lesions: Is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?

Journal of the American Academy of Dermatology, 2012-06, Vol.66 (6), p.911-916.e8

2012

Volltextzugriff (PDF)

A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections

Journal of immunological methods, 2005-04, Vol.299 (1), p.139-151

2005

Volltextzugriff (PDF)

HLA class I defects in malignant lesions: What have we learned?

The Keio Journal of Medicine, 2003, Vol.52(4), pp.220-229

2003

Volltextzugriff (PDF)

Immunotherapy of Melanoma Targeting Human High Molecular Weight Melanoma-Associated Antigen: Potential Role of Nonimmunological Mechanisms

Annals of the New York Academy of Sciences, 2004-12, Vol.1028 (1), p.340-350

2004

Volltextzugriff (PDF)

Development and validation of a nomogram incorporating gene expression profiling and clinical factors for accurate prediction of metastasis in patients with cutaneous melanoma following Mohs micrographic surgery

Journal of the American Academy of Dermatology, 2022-04, Vol.86 (4), p.846-853

2022

Volltextzugriff (PDF)

HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition: Prognostic Impact of Anti-Cancer Immune Responses

Seminars in immunopathology, 2011, Vol.33 (4), p.321-334

2011

Volltextzugriff (PDF)

HLA class I antigen loss, tumor immune escape and immune selection

Vaccine, 2002-12, Vol.20, p.A40-A45

2002

Volltextzugriff (PDF)

Immunotherapy of malignant disease with tumor antigen (TA)-specific monoclonal antibodies: does its therapeutic efficacy require cooperation with TA-specific CTL?

Clinical cancer research, 2009-12, Vol.16 (1), p.11-20

2009

Volltextzugriff (PDF)

HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?

Current opinion in immunology, 2004-10, Vol.16 (5), p.644-650

2004

Volltextzugriff (PDF)

T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?

Expert review of vaccines, 2004-04, Vol.3 (2), p.171-187

2004

Volltextzugriff (PDF)

A fresh look at an old story: revisiting HLA class II antigen expression by melanoma cells

Expert Review of Dermatology, 2006-12, Vol.1 (6), p.805-823

2006

Volltextzugriff (PDF)

Anti-inflammatory biologic therapies and immune surveillance of melanoma

Expert review of dermatology, 2008-04, Vol.3 (2), p.129-131

2008

Volltextzugriff (PDF)

Mechanisms of Tumor Evasion

Cancer treatment and research, 2005, Vol.123, p.61-88

2005

Volltextzugriff (PDF)

Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies

Journal of immunological methods, 2004-11, Vol.294 (1), p.23-35

2004

Volltextzugriff (PDF)

Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy

The Journal of immunology (1950), 2005-02, Vol.174 (3), p.1462-1471

2005

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(32)
Dissertationen
(1)

Sprache

Englisch
(32)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(20)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Animals
(11)
Immunology
(9)
Immunotherapy
(8)
Melanoma
(8)
Neoplasms - Immunology
(8)
Biological And Medical Sciences
(7)
Oncology
(7)
Cancer
(6)
Antigen Processing Machinery
(5)
Histocompatibility Antigens Class I - Immunology
(5)
Immune Escape
(5)
Medical Sciences
(5)
Pathology
(5)
Antigens, Neoplasm - Immunology
(4)
Dermatology
(4)
Immunohistochemistry
(4)
Biochemistry & Molecular Biology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study

Functional and Clinical Relevance of Chondroitin Sulfate Proteoglycan 4

HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition

Immunotherapy of Malignant Disease with Tumor Antigen–Specific Monoclonal Antibodies

A prospective evaluation of the clinical, histologic, and therapeutic variables associated with incidental perineural invasion in cutaneous squamous cell carcinoma

Human Leukocyte Antigen and Antigen Processing Machinery Component Defects in Astrocytic Tumors

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

Immune Selection of Hot-Spot β2 -Microglobulin Gene Mutations, HLA-A2 Allospecificity Loss, and Antigen-Processing Machinery Component Down-Regulation in Melanoma Cells Derived from Recurrent Metastases following Immunotherapy

Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance

Classical and Nonclassical HLA Class I Antigen and NK Cell–Activating Ligand Changes in Malignant Cells: Current Challenges and Future Directions

HLA antigen expression in melanocytic lesions: Is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?

A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections

HLA class I defects in malignant lesions: What have we learned?

Immunotherapy of Melanoma Targeting Human High Molecular Weight Melanoma-Associated Antigen: Potential Role of Nonimmunological Mechanisms

Development and validation of a nomogram incorporating gene expression profiling and clinical factors for accurate prediction of metastasis in patients with cutaneous melanoma following Mohs micrographic surgery

HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition: Prognostic Impact of Anti-Cancer Immune Responses

HLA class I antigen loss, tumor immune escape and immune selection

Immunotherapy of malignant disease with tumor antigen (TA)-specific monoclonal antibodies: does its therapeutic efficacy require cooperation with TA-specific CTL?

HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?

T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?

A fresh look at an old story: revisiting HLA class II antigen expression by melanoma cells

Anti-inflammatory biologic therapies and immune surveillance of melanoma

Mechanisms of Tumor Evasion

Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies

Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy

Suchergebnisse filtern